Xiang Yifei, Li Ziyang, Liu Chengzhi, Wei Zhifei, Mo Xuelian, Zhong Yawen, He Ruini, Liang Zhengmin, He Yucheng, He Jiakang
College of Animal Science and Technology, Guangxi University, Nanning, China.
Guangxi Key Laboratory of Animal Breeding, Disease Control and Prevention, Nanning, China.
Front Vet Sci. 2025 May 14;12:1603107. doi: 10.3389/fvets.2025.1603107. eCollection 2025.
Subclinical mastitis (SCM) caused by () is widely prevalent in cattle herds around the world, causing huge losses to the dairy cattle farming industry and dairy product production. Currently, the use of hormones and antibacterial drugs is the most effective treatment method. However, issues such as the increase in drug resistance and residues in dairy products limit their further application. In this study, based on the response surface optimization method, extract (PCE) was prepared from using ethanol as the medium in a simple, efficient and low-cost way. Its functions were verified both and .
Through the Oxford cup method, MIC/MBC and co-culture experiments, it was demonstrated that PCE had a good inhibitory effect on the proliferation of four strains of . The toxicity evaluation proved that PCE had high oral safety. In addition, we screened and established a mastitis model platform for lactating mice to evaluate the expected effects of PCE. The results showed that pre-treatment with PCE for 7 days significantly reduced the bacterial load and the levels of inflammatory factors (IL-6, IL-1β, TNF-α, MPO) in the mammary gland and blood induced by , improved the pathological damage of the mammary gland tissue, and alleviated the occurrence of mastitis in mice by regulating the intestinal microbiota.
These results verify that PCE can be used to treat mastitis caused by , and thus it is expected to become an excellent alternative to hormones and antibacterial drugs.
由()引起的亚临床乳腺炎(SCM)在世界各地的牛群中广泛流行,给奶牛养殖业和乳制品生产造成了巨大损失。目前,使用激素和抗菌药物是最有效的治疗方法。然而,耐药性增加和乳制品中残留等问题限制了它们的进一步应用。在本研究中,基于响应面优化方法,以乙醇为介质,以简单、高效、低成本的方式从()中制备了提取物(PCE)。其功能在体内和体外均得到了验证。
通过牛津杯法、MIC/MBC和共培养实验,证明PCE对四株()的增殖具有良好的抑制作用。急性毒性评价证明PCE具有较高的口服安全性。此外,我们筛选并建立了泌乳小鼠乳腺炎模型平台,以评估PCE的预期效果。结果表明,PCE预处理7天可显著降低由()诱导的乳腺和血液中的细菌载量以及炎症因子(IL-6、IL-1β、TNF-α、MPO)水平,改善乳腺组织的病理损伤,并通过调节肠道微生物群减轻小鼠乳腺炎的发生。
这些结果证实PCE可用于治疗由()引起的乳腺炎,因此有望成为激素和抗菌药物的优良替代品。